Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor

Company Dossier · Health Care

Molina Healthcare

MOHNYSEManaged Health CareWILMINGTON, US-DE, USLarge capWebsite ↗
  • Russell 1000
  • MidCap 400

What Molina Healthcare is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.

Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →

The latest read

Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.

  • Revenue over the four quarters to June 30, 2026: $44.5 billion, up 2.6% from a year earlier.SEC EDGAR filings (XBRL)
  • Free cash flow (operating cash flow minus capital expenditure) over the four quarters to September 30, 2025: −$0.57 billion.SEC EDGAR filings (XBRL)
  • Capital expenditure over the four quarters to September 30, 2025: $0.11 billion.SEC EDGAR filings (XBRL)
  • Share buybacks in the fiscal year to December 31, 2025: $1.00 billion.SEC EDGAR filings (10-K)
  • Long-term debt issued in the fiscal year to December 31, 2025: $0.84 billion.SEC EDGAR filings (10-K)
  • Latest earnings call or results release (July 23, 2026): sentiment -0.20 on a −1 to +1 scale (negative), confidence 0.80 of 1.Palanor Discourse
  • Guidance in the last 90 days: 1 outlook figure raised, 0 lowered, 2 held.Guidance Ledger (8-K results releases)
  • Latest annual report (filed February 10, 2026): 0 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
  • Insiders were net sellers in Q2 2026: $3.4 million on the open market.SEC Form 4
  • 601 institutional managers reported a position at June 30, 2026 (+74 on the quarter before).SEC Form 13F
  • H-1B filings certified in Q2 2026: 11 (18 a year earlier).U.S. Department of Labor (OFLC)

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for Molina Healthcare yet.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Cash flow

Business

Molina Healthcare: free cash flow, trailing twelve months

Operating cash flow minus capital expenditure, $ billions, from SEC filings

−$0.6BData to Sep 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: operating cash flow and capital expenditure

Trailing twelve months, $ billions, from SEC filings

Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: revenue, trailing twelve months

$ billions, from SEC filings

$44.5BData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Capital returned and raised

Business

Molina Healthcare: share buybacks by fiscal year

Cash paid to repurchase common stock, $ billions, from the 10-K

$1.0BData to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: debt issued and repaid by fiscal year

Long-term debt, $ billions, from the 10-K

Data to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: debt due within a year and cash

At each balance-sheet date, $ billions, from SEC filings

Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: interest coverage

Operating income ÷ interest expense, trailing twelve months, from SEC filings

1.0Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

What the company says

Business

Molina Healthcare: guidance raised minus lowered

Guidance Ledger statements by quarter

1.0Data today
ImageDataGuidance Ledger by Palanor · source: SEC EDGAR
Business

Molina Healthcare: earnings call sentiment

Palanor Discourse score per call, −1 to +1

−0.20Data to Jul 2026
ImageDataPalanor calculation
Business

Molina Healthcare: earnings call confidence

Palanor Discourse score per call, 0 to 1

0.80Data to Jul 2026
ImageDataPalanor calculation
Business

Molina Healthcare: risk factors added per annual report

New Item 1A risk factors in each 10-K

0.0Data to Feb 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: medical Care Ratio (MCR)

KPI Ledger, as reported in the company's results releases, %

92.2Data to Jun 2026
ImageDataKPI Ledger by Palanor · source: SEC EDGAR

Hiring and ownership

Business

Molina Healthcare: H-1B filings certified

Labor Condition Applications by quarter received

11.0Data to Jun 2026
ImageDataU.S. Department of Labor, Office of Foreign Labor Certification disclosure data, dol.gov
Business

Molina Healthcare: insider net buying

Open-market purchases minus sales by officers and directors, $ millions, by quarter

−$3.4MData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Molina Healthcare: institutional holders

Managers reporting a position on Form 13F, by quarter

601.0Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

In the news

Headlines that name Molina Healthcare, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.

30 days
1 headlines
0% positive · 0% negative
90 days
1 headlines
0% positive · 0% negative

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

  1. Oct 20, 2026Lobbying
    Lobbying report (MEHLMAN CONSULTING, INC.)third_quarter 2026 · $0.1 million
  2. Oct 14, 2026Lobbying
    Lobbying report (MOLINA HEALTHCARE, INC.)third_quarter 2026 · $0.2 million
  3. Aug 14, 2026Lobbying
  4. Jul 20, 2026Lobbying
  5. Jul 17, 2026Lobbying
    Lobbying report (MEHLMAN CONSULTING, INC.)second_quarter 2026 · $0.1 million
  6. Jul 16, 2026Lobbying
    Lobbying report (MOLINA HEALTHCARE, INC.)second_quarter 2026 · $0.2 million
  7. Jun 18, 2026Trademark
  8. May 11, 20268-K
  9. May 11, 20268-K
  10. Apr 20, 2026Lobbying
    Lobbying report (MEHLMAN CONSULTING, INC.)first_quarter 2026 · $0.1 million
  11. Apr 19, 2026Lobbying
  12. Feb 10, 202610-K
    Annual report (10-K)0 risk factors added, 0 removed
  13. Feb 6, 20268-K
  14. Feb 6, 20268-K
  15. Nov 20, 20258-K
  16. Aug 12, 20258-K
  17. May 1, 20258-K
  18. May 1, 20258-K
  19. Feb 21, 20258-K
  20. Feb 11, 202510-K
    Annual report (10-K)2 risk factors added, 1 removed
  21. Nov 18, 20248-K
  22. Feb 13, 202410-K
    Annual report (10-K)38 risk factors added, 10 removed

Peers

Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

CompanyRevenueFree cash flowThrough
Humana HUM$137B$1.3BMar 31, 2026
Centene Corporation CNC$179B$8.9BJun 30, 2026
Elevance Health ELV$201B$6.3BJun 30, 2026
Abbott Laboratories ABT$45.1B$7.4BMar 31, 2026
Thermo Fisher Scientific TMO$46.3B$7.3BJun 27, 2026
Bristol Myers Squibb BMY$49.2B$11.4BJun 30, 2026
Amgen AMGN$38.1B$10.2BJun 30, 2026
Medtronic MDT$37.5B$6.1BJul 31, 2026

Identity

SEC CIK
1179929
Wikidata
Q6896175

Built from SEC EDGAR filings (public domain), the Guidance and KPI Ledgers, Palanor Discourse, U.S. Department of Labor filings, USPTO, USAspending and Senate lobbying records, and rights-checked news headlines. Updated nightly; this page was built Oct 22, 2026. How the Dossier is built

S&P 500, S&P 100, S&P MidCap 400 and Dow Jones Industrial Average are trademarks of S&P Dow Jones Indices LLC or its affiliates; Nasdaq-100 is a trademark of Nasdaq, Inc.; Russell 1000 is a trademark of FTSE Russell. Membership is shown for identification only. Palanor is not affiliated with or endorsed by the index owners.

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.